Folgen
Dr Estee Torok
Titel
Zitiert von
Zitiert von
Jahr
Dexamethasone in hospitalized patients with Covid-19
RECOVERY Collaborative Group
New England Journal of Medicine 384 (8), 693-704, 2021
11364*2021
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
52212021
SARS-CoV-2 variants, spike mutations and immune escape
WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ...
Nature Reviews Microbiology 19 (7), 409-424, 2021
30232021
Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England
NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ...
Science 372 (6538), eabg3055, 2021
24712021
Effect of hydroxychloroquine in hospitalized patients with Covid-19
RECOVERY Collaborative Group
New England Journal of Medicine 383 (21), 2030-2040, 2020
14432020
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13082021
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ...
Nature 599 (7883), 114-119, 2021
11672021
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England
E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ...
Nature 593 (7858), 266-269, 2021
10622021
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
10482021
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study
T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ...
The lancet 399 (10332), 1303-1312, 2022
10472022
Tuberculous meningitis: a uniform case definition for use in clinical research
S Marais, G Thwaites, JF Schoeman, ME Török, UK Misra, K Prasad, ...
The Lancet infectious diseases 10 (11), 803-812, 2010
9592010
SARS-CoV-2 evolution during treatment of chronic infection
SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ...
Nature 592 (7853), 277-282, 2021
9012021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
834*2022
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ...
Nature 603 (7902), 706-714, 2022
8002022
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ...
The Lancet 396 (10259), 1345-1352, 2020
7892020
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ...
The Lancet 397 (10282), 1351-1362, 2021
7282021
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ...
Nature 593 (7857), 136-141, 2021
6932021
Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study
SR Harris, EJP Cartwright, ME Török, MTG Holden, NM Brown, ...
The Lancet infectious diseases 13 (2), 130-136, 2013
6572013
The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis
M Caws, G Thwaites, S Dunstan, TR Hawn, N Thi Ngoc Lan, NTT Thuong, ...
PLoS pathogens 4 (3), e1000034, 2008
6482008
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
DA Collier, IATM Ferreira, P Kotagiri, RP Datir, EY Lim, E Touizer, B Meng, ...
Nature 596 (7872), 417-422, 2021
6102021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20